Related Experiment Video
Updated: Aug 6, 2026
10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
10.4K
DSPE-mPEG2000-Modified Podophyllotoxin Long-Circulating Liposomes for Targeted Delivery: Their Preparation,
Langlang Zhang1, Rongyu Li1, Han Zhang2
1Department of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Current Drug Delivery
|January 6, 2025
Summary
Long-circulating podophyllotoxin liposomes (Lc-PTOX-Lps) modified with DSPE-mPEG2000 showed enhanced stability, prolonged circulation, and improved anticancer efficacy against MCF-7 cells with reduced toxicity. This simple method yields promising anticancer agents.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Phospholipid-polyethylene glycol conjugates like DSPE-mPEG2000 are crucial for drug delivery systems, enhancing liposome stability and drug efficacy.
- DSPE-mPEG2000's amphipathic nature allows it to form stable liposomal structures, improving drug encapsulation and controlled release.
Purpose of the Study:
- To synthesize and characterize long-circulating podophyllotoxin liposomes (Lc-PTOX-Lps) using DSPE-mPEG2000.
- To evaluate the pharmacokinetic profile and in vitro anticancer activity of Lc-PTOX-Lps.
Main Methods:
- Preparation of Lc-PTOX-Lps using DSPE-mPEG2000 as a surface-modifying agent.
- Characterization of liposome properties including encapsulation rate, particle size, polydispersity index, and zeta potential.
- In vitro drug release studies, pharmacokinetic analysis, and assessment of anticancer effects on MCF-7 cells.
Main Results:
- Lc-PTOX-Lps exhibited high encapsulation efficiency (87.11±1.77%) and optimal particle size (168.91±7.07 nm).
- The liposomes demonstrated sustained drug release, improved stability, prolonged half-life, reduced clearance, and enhanced bioavailability compared to free drug.
- Significant anticancer activity against MCF-7 cells was observed, alongside lower toxicity to normal cells.
Conclusions:
- A straightforward and effective method was developed for synthesizing DSPE-mPEG2000-modified Lc-PTOX-Lps.
- These Lc-PTOX-Lps represent a promising nanocarrier for anticancer drug delivery, offering improved therapeutic potential.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...